You are here: Home » PTI Stories » National » News
Business Standard

General Atlantic acquires significant stake in Rubicon Research

Business Finance

Press Trust of India  |  New Delhi 

Growth equity firm General Atlantic has acquired a significant stake in drug development company Rubicon Research, which intends to focus its efforts on bringing innovative medicines to market with the deal.

"General Atlantic is committing up to USD 100 million of primary capital and has acquired the stake held by Rubicon's existing private equity shareholders," the companies said in a joint statement.

All other existing shareholders continue to maintain their holding in the company, it added.

The companies, however, did not disclose more details about the deal.

With this investment, Rubicon intends to focus its efforts on bringing innovative medicines to market to address fundamental needs of patients through the use of its proprietary drug delivery technologies.

Also, it is looking to increase its manufacturing footprint across the world, the statement said.

"We welcome this partnership with General Atlantic and believe that with their growth focus, capital resources, strategic outlook and global connectivity, Rubicon will be able to accelerate its growth through organic and inorganic effort," Rubicon founder and CEO Pratibha Pilgaonkar said.

Sandeep Naik and Shantanu Rastogi from General Atlantic will join the board of Rubicon, the statement said.

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Mon, April 08 2019. 18:25 IST